Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapsone 5% vs erythromycin 2% in mild papulopustular acne
IRCT201607232581N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acne vulgaris comparing Dapsone 5% topical with Erythromycin 2% topical (2 arms). Started Nov 2016; status: completed.
02
Drugs
dapsoneerythromycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT201607232581N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201607232581N5.